The largest database of trusted experimental protocols

47 protocols using chloramphenicol

1

Growth and Selection of Clostridium perfringens

Check if the same lab product or an alternative is used in the 5 most similar protocols
Clostridium perfringens strains F5603, NCTC8533, ATCC3624, and strain 13 were used in this study [8 (link)-10 (link)]. For the growth of these strains, TGY medium (3 % tryptic soy broth [TSB] [BD Bioscience, Tokyo, Japan], 2 % glucose, 1 % yeast extract [BD Bioscience, Tokyo, Japan], and 0.1 % L-cysteine [Wako Pure Chemical, Osaka, Japan]) with or without chloramphenicol (10 μg/ml) (Wako Pure Chemical, Osaka, Japan) was used as previously described [8 (link), 9 (link)]. E. coli HB101 was used as the host for the recombinant plasmids used for DNA sequencing or for constructing recombinant plasmids carrying the putative replication region from C. perfringens plasmids. For the selection of E. coli or C. perfringens transformants, TSB agar containing ampicillin (100 μg/ml) (Wako Pure Chemical, Osaka, Japan) or chloramphenicol (30 μg/ml) and Brain Heart Infusion (BHI) (BD Bioscience, Tokyo, Japan) agar with chloramphenicol (15 μg/ml) were used, respectively.
+ Open protocol
+ Expand
2

Antimicrobial Resistance Profiling of Bacteria

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antimicrobial resistance profiling was performed using the most representative antimicrobial agents from the different antibiotic families, which are of great clinical and epidemiological relevance. Kirby-Bauer disk diffusion or broth microdilution methods (in the case of colistin) were done according to Clinical and Laboratory Standards Institute (CLSI) guidelines (CLSI, 2020 ). Escherichia coli ATCC 25922 was used as a control strain. The antimicrobials tested by disk diffusion were: amoxicillin/clavulanate (20/10 μg), ampicillin (10 μg), aztreonam (30 μg), cefepime (30 μg), cefotaxime (30 μg), ceftazidime (30 μg), chloramphenicol (30 μg), ciprofloxacin (5 μg), fosfomycin (200 μg/50 μg of glucose-6-phosphate), gentamicin (10 μg), imipenem (10 μg), meropenem (10 μg), and trimethoprim-sulfamethoxazole (1.25/23.75 μg) (Becton Dickinson). Extended-spectrum beta-lactamases were screened by the ESBL test following the CLSI guidelines (CLSI, 2020 ). Isolates were classified as susceptible, resistant to 1 or 2 antimicrobial categories, multidrug-resistant (MDR) if resistant to at least one agent in ≥ 3 antimicrobial categories; or extensively drug-resistant (XDR), if resistant to at least one agent in all but two or fewer antimicrobial categories (Magiorakos et al., 2012 (link)).
+ Open protocol
+ Expand
3

Antimicrobial Susceptibility Testing Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antimicrobial susceptibility testing was performed using the disk-diffusion method and the antibiotics ampicillin (AM), amoxicillin-clavulanic acid (AMC), cefotaxime (CTX), nalidixic acid (Na), ciprofloxacin (CIP), gentamicin (GM), kanamycin (K), streptomycin (S), sulfamethoxazole (Su), trimethoprim (TMP), tetracycline (T), and chloramphenicol (C) (Becton Dickinson, Heidelberg, Germany). Results were interpreted according to Clinical and Laboratory Standards Institute (CLSI) performance standards (CLSI, 2016 ). For sulfamethoxazole, for which breakpoints are not listed separately from trimethoprim, an inhibition zone of ≤10 mm was interpreted as resistant. Isolates displaying resistance to three or more classes of antimicrobials (counting β-lactams as one class) were defined as multidrug-resistant (MDR). Synergistic effects between AMC and CTX were regarded as an indication of the presence of an ESBL producer (Kaur et al., 2013 (link)).
+ Open protocol
+ Expand
4

Antimicrobial Susceptibility Testing Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antimicrobial susceptibility tests were performed using the agar disk diffusion method according to the guidelines of the Clinical and Laboratory Standards Institute (CLSI, 2023 ). Antimicrobial substances included chloramphenicol and linezolid (Becton, Dickinson, Heidelberg, Germany). E. faecalis ATCC 29212 was used as a quality control strain. Zone diameters were interpreted according to the CLSI (2023 ). Zone diameter breakpoints were ≤ 12 mm for chloramphenicol and ≤ 20 mm for linezolid, respectively. For bacterial genera where interpretive criteria for susceptibility testing are not available, the CLSI classification was not applied.
+ Open protocol
+ Expand
5

Antimicrobial Susceptibility of Bacterial Isolates

Check if the same lab product or an alternative is used in the 5 most similar protocols
The antimicrobial agents were selected among those commonly carried by integrons. Antimicrobial susceptibility testing was performed using disc diffusion method according to the Clinical and Laboratory Standards Institute (CLSI) guidelines for each bacterial species (15 , 16 ), for ampicillin (10 µg), chloramphenicol (30 µg), streptomycin (10 µg) (Becton Dickinson, Sparks, Maryland, USA), cotrimoxazole (25 µg), tetracycline (30 µg), ciprofloxacin (5 µg) (Difco Laboratories, Detroit, Michigan, USA), and trimethoprim (Mast Diagnostics Ltd, Bootle, Merseyside, UK) (5 µg) (15 , 16 ). The antimicrobials were classified as aminoglycosides (STR, AMP), tetracyclines (TE), amphenicols (CHL), fluoroquinolones (CIP), trimethoprim alone (TMP), or in combination with sulfonamides (SXT).
+ Open protocol
+ Expand
6

Antibiotic Susceptibility Testing Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Kirby–Bauer disc diffusion test was performed using Mueller–Hinton agar plates (Becton, Dickenson and Company) according to Clinical and Laboratory Standard Institute standards [23] using the following antimicrobials: ampicillin (10 µg), cefazolin (30 µg), kanamycin (30 µg), streptomycin (10 µg), tetracycline (30 µg), chloramphenicol (30 µg), fosfomycin (50 µg), colistin (10 µg), sulfamethizole (250 µg), and nalidixic acid (30 µg) (Becton, Dickinson and Company).
+ Open protocol
+ Expand
7

Rasamsonia Detection in Cystic Fibrosis

Check if the same lab product or an alternative is used in the 5 most similar protocols
In total, 214 samples from 138 CF patients (one to four samples per patient) attending the
University Hospital Essen and the Clinic of the Ruhr, West German Lung Centre, Essen, Germany, in
2012 were tested for the presence of DNA from Rasamsonia species as mentioned
above. For culturing, 100 μL of the sputasol-pretreated respiratory samples were
inoculated on malt agar (Oxoid) and incubated aerobically at 36°C for 2 days and then
at 22°C for an additional 8 days.
In addition, 20 sputum samples from 15 CF patients followed up in Angers University Hospital,
Angers, France, were also analysed. Mycological examination of these samples performed in parallel
to the PCR assay consisted of the inoculation of 10-μL aliquots of the digested samples on
CHROMagar Candida (Becton-Dickinson, Franklin, NJ, USA), yeast extract-peptone-dextrose agar (YPDA)
supplemented with chloramphenicol and gentamicin (Becton-Dickinson), Dichloran-rose
bengale-chloramphenicol agar (DRBC), YPDA supplemented with chloramphenicol and cycloheximide, and
erythritol agar. Incubation was carried out at 37°C for 2 weeks, except for the last
two culture media, which were incubated at 25°C. Mould isolates were identified by cultural
and microscopic morphological characteristics.
+ Open protocol
+ Expand
8

Antimicrobial Susceptibility Testing of Isolates

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antimicrobial susceptibility testing (AST) was conducted on the isolates using the disk-diffusion method according to the guidelines of the Clinical and Laboratory Standards Institute (CLSI) [11 ]. Antimicrobial substances included ampicillin, amoxicillin/clavulanic acid, cefazolin, cefotaxime, cefepime, nalidixic acid, ciprofloxacin, sulfamethoxazole-trimethoprim, fosfomycin, azithromycin, nitrofurantoin, streptomycin, kanamycin, gentamicin, chloramphenicol, and tetracycline (Becton, Dickinson, Heidelberg, Germany). Results were interpreted according to CLSI breakpoints for human clinical isolates [11 ]. Multidrug resistance (MDR) was defined as resistance to three or more classes of antimicrobials, counting beta-lactams as one class.
+ Open protocol
+ Expand
9

Antibiotic Resistance Screening in Environmental Isolates

Check if the same lab product or an alternative is used in the 5 most similar protocols
Samples were first plated on Chromocult agar, and then presumptive E. coli colonies were transferred onto MacConkey lactose (MKL) agar for confirmation before replating on Chromocult was performed to ensure pure isolates. We selected up to four E. coli colonies from soil and fecal samples and two from water and surface samples to test for AR. More isolates from soil samples than from water or surfaces were used because we expected higher microbial diversity in soil. Antibiotic sensitivity was assessed using the Kirby-Bauer disc diffusion method (43 (link)) and 12 antibiotics: ampicillin, amoxicillin/clavulanate, cefotaxime, cephalothin, chloramphenicol, ciprofloxacin, enrofloxacin, gentamicin, streptomycin, sulfisoxazole, trimethoprim-sulfamethoxazole, and tetracycline (Becton, Dickinson, Franklin Lakes, NJ). Zones of inhibition were measured after a 24-h incubation period using digital calipers.
+ Open protocol
+ Expand
10

Antimicrobial Susceptibility of S. aureus

Check if the same lab product or an alternative is used in the 5 most similar protocols
The antimicrobial susceptibility of S. aureus strains was tested by disk diffusion method using penicillin G, erythromycin, clindamycin, ciprofloxacin, tetracycline, gentamicin, sulfamethoxazole/trimethoprim, chloramphenicol and fusidic acid discs from Becton Dickinson (Franklin Lakes, NJ, USA) and was interpreted according to the Clinical and Laboratory Standards Institute (CLSI).14 MIC for vancomycin was determined by E-tests, in line with the manufacturer’s instructions (AB Biodisc, Solna, Sweden).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!